Ameriprise’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Ameriprise’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-16,240	Closed	-$102K	–	5798
2013 Q2	$102K	Buy	+16,240	New	+$97.3K	﹤0.01%	3381

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Ameriprise's PBTH Position: Q3 2013 in Review

Ameriprise sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 16,240 shares — an estimated $102K sold.

Ameriprise first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $102K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Ameriprise reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Ameriprise sold 16,240 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $102K.
Ameriprise first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Ameriprise's PROLOR Biotech, Inc. Common Stock position peaked at $102K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Ameriprise's 13F filing for Q3 2013, filed 14 Nov 2013.